Nautilus Biotechnolgy, Inc. Common Stock (NAUT) is a publicly traded Healthcare sector company. As of May 21, 2026, NAUT trades at $2.38 with a market cap of $299.91M and a P/E ratio of -5.01. NAUT moved +0.00% today. Year to date, NAUT is +25.93%; over the trailing twelve months it is +189.54%. Its 52-week range spans $0.62 to $4.31. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces NAUT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nautilus Biotechnolgy, Inc. Common Stock (NAUT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NAUT moved +0.00% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $2.38 |
| Market Cap | $299.91M |
| P/E Ratio | -5.01 |
| EPS | $-0.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.31 |
| 52-Week Low | $0.62 |
| Volume | 313.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-59.00M |
| Gross Margin | 0.00% |
2 analysts cover NAUT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.